AIIMS to Begin Booster Trial of Bharat Biotech’s Intranasal Vaccine Today on Those Jabbed With Covaxin, Covishield
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
Fully vaccinated international passengers from 82 countries will be permitted quarantine-free entry from February 14, the Ministry of Health and
The country recorded 71,550 new COVID-19 cases on Tuesday. The total number of infections has reached 4.23 crore, and the
The country recorded 65,513 new Covid-19 cases on Monday. The total number of infections has reached 4.22 crore, and the
The country recorded 84,474 new COVID-19 cases on Sunday. The total number of infections has reached 4.22 crore, and the
The country recorded 1,06,953 new Covid-19 cases on Saturday. The total number of infections has reached 4.21 crore, and the
Bharat Biotech is set to carry out a study to assess the level of protection given by the mix and
Bharat Biotech is set to carry out a study to assess the level of protection given by the mix and
AIIMS expert Dr Sanjay Rai talked about the effectiveness of the Bharat Biotech nasal vaccine against the Covid-19 infection.
The country recorded 2,30,920 new COVID-19 cases on Saturday. The total number of infections has reached 4.08 crore, and the
The DGCI also approved the market sale of Bharat Biotech’s Covaxin and Serum Institute of India’s Covishield
Bharat Biotech has received approval from the Drug Controller General of India to conduct phase-3 trials for its COVID-19 intra-nasal